ro 32-3555 has been researched along with zd 8321 in 1 studies
| Studies (ro 32-3555) | Trials (ro 32-3555) | Recent Studies (post-2010) (ro 32-3555) | Studies (zd 8321) | Trials (zd 8321) | Recent Studies (post-2010) (zd 8321) |
|---|---|---|---|---|---|
| 15 | 1 | 4 | 5 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbenante, G; Fairlie, DP; Leung, D | 1 |
1 review(s) available for ro 32-3555 and zd 8321
| Article | Year |
|---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |